What one pharmacist suggests President Trump should do to help pharmacists and their patients.
Peter Kreckel recently tried to explain DIR fees to students. Here’s how it went.
Meaningful changes to DIR fees are on the horizon—will pharmacies see an increase in reimbursements?
Reimbursement issues, sadly, aren’t anything new for pharmacies.
A new rule in Ohio is designed to bring transparency to drug prices in the pharmacy.
The Father of Vitamins was an incredibly important person who went unthanked—just like pharmacists.
CMS is considering big changes to DIR fees and pharmacists are excited.
As pharmacist salaries rise, so do demands.
NCPA CEO B. Douglas Hoey, RPh, MBA, discusses the problems and opportunities facing independent pharmacies.
A new NCPA report highlights the role of community pharmacies.